News summary
Newsletter text
[Kenneth Walton Hitchner III increases its stake in Cornerstone Pharmaceuticals-B]
April 9 to April 19, 2024, Keystone Pharmaceuticals-Bcrashbandicoottrilogyps5Kenneth Walton Hitchner III, non-executive director of the company, posted a bid of HKD 0 on the open marketcrashbandicoottrilogyps5.86 Average price purchase 221crashbandicoottrilogyps5.950,000 shares of the company.
After the increase, Mr. Hitchner will hold approximately 2.6135 million shares, accounting for 0.20% of the company's total issued share capital on the announcement date.
Mr. Hitchner said he is confident in the future of Cornerstone Pharmaceuticals-B and believes that the company can maintain stable operations and achieve rapid growth despite market fluctuations.
In addition, Mr. Hitchner did not rule out the possibility of continuing to increase his stake in the company.
（crashbandicoottrilogyps5: Congratulations
